Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

NextGen Healthcare

Nasdaq:NXGN
Snowflake Description

Excellent balance sheet and good value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
NXGN
Nasdaq
$611M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

NextGen Healthcare, Inc. provides ambulatory-focused healthcare software and services solutions in the United States. The last earnings update was 70 days ago. More info.


Add to Portfolio Compare Print
  • NextGen Healthcare has significant price volatility in the past 3 months.
NXGN Share Price and Events
7 Day Returns
-6.3%
NasdaqGS:NXGN
2.4%
US Healthcare Services
-4.1%
US Market
1 Year Returns
-47.3%
NasdaqGS:NXGN
16.3%
US Healthcare Services
-14.9%
US Market
NXGN Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
NextGen Healthcare (NXGN) -6.3% -27.5% -41% -47.3% -36.9% -42.1%
US Healthcare Services 2.4% -4.3% -2.4% 16.3% 61.9% 36.3%
US Market -4.1% -19.1% -23.4% -14.9% 3.5% 14.5%
1 Year Return vs Industry and Market
  • NXGN underperformed the Healthcare Services industry which returned 16.3% over the past year.
  • NXGN underperformed the Market in United States of America which returned -14.9% over the past year.
Price Volatility
NXGN
Industry
5yr Volatility vs Market

NXGN Value

 Is NextGen Healthcare undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of NextGen Healthcare to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for NextGen Healthcare.

NasdaqGS:NXGN Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 12 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7.5%
Perpetual Growth Rate 10-Year US Government Bond Rate 1.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqGS:NXGN
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 1.7%
Equity Risk Premium S&P Global 5.4%
Healthcare Services Unlevered Beta Simply Wall St/ S&P Global 0.97
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.974 (1 + (1- 21%) (14.18%))
1.056
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.06
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.74% + (1.056 * 5.44%)
7.48%

Discounted Cash Flow Calculation for NasdaqGS:NXGN using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for NextGen Healthcare is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

NasdaqGS:NXGN DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 7.48%)
2020 54.30 Analyst x3 50.52
2021 52.31 Analyst x3 45.28
2022 50.22 Analyst x3 40.44
2023 42.00 Analyst x1 31.47
2024 53.20 Analyst x1 37.08
2025 62.00 Analyst x1 40.21
2026 66.22 Est @ 6.8% 39.95
2027 69.72 Est @ 5.28% 39.14
2028 72.66 Est @ 4.22% 37.95
2029 75.19 Est @ 3.48% 36.53
Present value of next 10 years cash flows $398.00
NasdaqGS:NXGN DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $75.19 × (1 + 1.74%) ÷ (7.48% – 1.74%)
$1,331.74
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $1,331.74 ÷ (1 + 7.48%)10
$647.11
NasdaqGS:NXGN Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $398.00 + $647.11
$1,045.11
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $1,045.11 / 65.70
$15.91
NasdaqGS:NXGN Discount to Share Price
Calculation Result
Value per share (USD) From above. $15.91
Current discount Discount to share price of $9.30
= -1 x ($9.30 - $15.91) / $15.91
41.5%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price NextGen Healthcare is available for.
Intrinsic value
42%
Share price is $9.3 vs Future cash flow value of $15.91
Current Discount Checks
For NextGen Healthcare to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • NextGen Healthcare's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • NextGen Healthcare's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for NextGen Healthcare's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are NextGen Healthcare's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqGS:NXGN PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $0.24
NasdaqGS:NXGN Share Price ** NasdaqGS (2020-04-02) in USD $9.3
United States of America Healthcare Services Industry PE Ratio Median Figure of 12 Publicly-Listed Healthcare Services Companies 39.64x
United States of America Market PE Ratio Median Figure of 2,944 Publicly-Listed Companies 12.5x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of NextGen Healthcare.

NasdaqGS:NXGN PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGS:NXGN Share Price ÷ EPS (both in USD)

= 9.3 ÷ 0.24

38.68x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • NextGen Healthcare is good value based on earnings compared to the US Healthcare Services industry average.
  • NextGen Healthcare is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does NextGen Healthcare's expected growth come at a high price?
Raw Data
NasdaqGS:NXGN PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 38.68x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 12 Analysts
1.1%per year
United States of America Healthcare Services Industry PEG Ratio Median Figure of 11 Publicly-Listed Healthcare Services Companies 3.11x
United States of America Market PEG Ratio Median Figure of 2,008 Publicly-Listed Companies 0.91x

*Line of best fit is calculated by linear regression .

NasdaqGS:NXGN PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 38.68x ÷ 1.1%

34.7x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • NextGen Healthcare is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on NextGen Healthcare's assets?
Raw Data
NasdaqGS:NXGN PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $6.08
NasdaqGS:NXGN Share Price * NasdaqGS (2020-04-02) in USD $9.3
United States of America Healthcare Services Industry PB Ratio Median Figure of 38 Publicly-Listed Healthcare Services Companies 3.36x
United States of America Market PB Ratio Median Figure of 5,142 Publicly-Listed Companies 1.22x
NasdaqGS:NXGN PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGS:NXGN Share Price ÷ Book Value per Share (both in USD)

= 9.3 ÷ 6.08

1.53x

* Primary Listing of NextGen Healthcare.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • NextGen Healthcare is good value based on assets compared to the US Healthcare Services industry average.
X
Value checks
We assess NextGen Healthcare's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. NextGen Healthcare has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

NXGN Future Performance

 How is NextGen Healthcare expected to perform in the next 1 to 3 years based on estimates from 12 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
1.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is NextGen Healthcare expected to grow at an attractive rate?
  • NextGen Healthcare's earnings growth is positive but not above the low risk savings rate of 1.7%.
Growth vs Market Checks
  • NextGen Healthcare's earnings growth is positive but not above the United States of America market average.
  • NextGen Healthcare's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NasdaqGS:NXGN Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqGS:NXGN Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 12 Analysts 1.1%
NasdaqGS:NXGN Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 12 Analysts 6.2%
United States of America Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 23.8%
United States of America Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 14.4%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 12.2%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqGS:NXGN Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 12 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqGS:NXGN Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2025-03-31 805 1
2024-03-31 739 1
2023-03-31 625 16 3
2022-03-31 587 88 15 9
2021-03-31 560 81 12 12
2020-04-03
2020-03-31 543 83 14 12
NasdaqGS:NXGN Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 539 82 16
2019-09-30 532 76 16
2019-06-30 528 64 23
2019-03-31 529 50 24
2018-12-31 530 52 10
2018-09-30 531 51 6
2018-06-30 533 63 1
2018-03-31 531 74 2
2017-12-31 528 84 18
2017-09-30 524 92 27
2017-06-30 518 111 23
2017-03-31 510 110 18

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • NextGen Healthcare's earnings are expected to grow by 1.1% yearly, however this is not considered high growth (20% yearly).
  • NextGen Healthcare's revenue is expected to grow by 6.2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqGS:NXGN Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 12 Analyst Estimates (S&P Global) See Below

All data from NextGen Healthcare Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:NXGN Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2025-03-31
2024-03-31
2023-03-31 0.24 0.24 0.24 1.00
2022-03-31 0.22 0.37 0.05 5.00
2021-03-31 0.19 0.32 0.03 9.00
2020-04-03
2020-03-31 0.22 0.32 0.15 9.00
NasdaqGS:NXGN Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 0.24
2019-09-30 0.25
2019-06-30 0.36
2019-03-31 0.38
2018-12-31 0.15
2018-09-30 0.10
2018-06-30 0.02
2018-03-31 0.04
2017-12-31 0.28
2017-09-30 0.43
2017-06-30 0.37
2017-03-31 0.30

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • NextGen Healthcare is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess NextGen Healthcare's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
NextGen Healthcare has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

NXGN Past Performance

  How has NextGen Healthcare performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare NextGen Healthcare's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • NextGen Healthcare's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • NextGen Healthcare's 1-year earnings growth exceeds its 5-year average (64.6% vs -10%)
  • NextGen Healthcare's earnings growth has exceeded the US Healthcare Services industry average in the past year (64.6% vs 23.3%).
Earnings and Revenue History
NextGen Healthcare's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from NextGen Healthcare Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:NXGN Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 538.64 15.67 166.73 81.68
2019-09-30 531.77 16.08 164.79 82.34
2019-06-30 527.83 23.09 168.57 80.92
2019-03-31 529.17 24.49 170.58 80.99
2018-12-31 530.16 9.52 172.58 82.28
2018-09-30 531.01 6.24 174.84 82.24
2018-06-30 533.30 1.17 173.39 83.40
2018-03-31 531.02 2.42 174.23 81.26
2017-12-31 527.63 17.88 169.38 82.27
2017-09-30 523.78 26.83 165.36 81.34
2017-06-30 518.34 22.78 161.77 80.11
2017-03-31 509.62 18.24 159.38 78.34
2016-12-31 505.15 -2.50 158.39 72.31
2016-09-30 494.32 -5.68 157.86 67.11
2016-06-30 492.52 -1.35 157.45 66.80
2016-03-31 492.48 5.66 155.90 65.66
2015-12-31 492.95 32.72 155.64 67.22
2015-09-30 499.35 32.10 157.57 71.17
2015-06-30 494.50 28.53 158.88 70.09
2015-03-31 490.23 27.33 156.24 69.24
2014-12-31 477.04 21.79 154.04 66.72
2014-09-30 462.47 2.53 149.86 61.43
2014-06-30 453.03 7.90 150.29 52.15
2014-03-31 444.67 15.68 149.21 41.52
2013-12-31 440.76 6.39 147.05 34.64
2013-09-30 446.42 34.60 145.80 29.25
2013-06-30 451.46 40.17 144.92 27.90

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • NextGen Healthcare has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • NextGen Healthcare used its assets less efficiently than the US Healthcare Services industry average last year based on Return on Assets.
  • NextGen Healthcare's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess NextGen Healthcare's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
NextGen Healthcare has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

NXGN Health

 How is NextGen Healthcare's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up NextGen Healthcare's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • NextGen Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • NextGen Healthcare's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of NextGen Healthcare's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 4.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from NextGen Healthcare Company Filings, last reported 3 months ago.

NasdaqGS:NXGN Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 399.76 37.00 26.79
2019-09-30 391.13 0.00 42.93
2019-06-30 380.83 6.00 28.61
2019-03-31 375.95 11.00 33.08
2018-12-31 365.37 27.00 30.05
2018-09-30 355.43 42.00 32.39
2018-06-30 336.89 44.00 26.54
2018-03-31 323.41 37.00 28.85
2017-12-31 330.74 39.00 23.36
2017-09-30 325.50 55.00 26.55
2017-06-30 314.19 45.00 23.34
2017-03-31 305.04 15.00 37.67
2016-12-31 297.75 25.00 23.99
2016-09-30 285.47 48.00 26.25
2016-06-30 270.13 88.00 26.35
2016-03-31 269.38 105.00 36.47
2015-12-31 284.58 0.00 104.81
2015-09-30 287.50 0.00 110.78
2015-06-30 279.95 0.00 116.80
2015-03-31 283.54 0.00 130.59
2014-12-31 282.50 0.00 124.82
2014-09-30 285.38 0.00 123.52
2014-06-30 290.54 0.00 116.44
2014-03-31 295.09 0.00 113.80
2013-12-31 299.74 0.00 93.99
2013-09-30 320.50 0.00 84.31
2013-06-30 310.10 0.00 130.03
  • NextGen Healthcare's level of debt (9.3%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if NextGen Healthcare's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (220.5%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 15.5x coverage).
X
Financial health checks
We assess NextGen Healthcare's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. NextGen Healthcare has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

NXGN Dividends

 What is NextGen Healthcare's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from NextGen Healthcare dividends. Estimated to be 0% next year.
If you bought $2,000 of NextGen Healthcare shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate NextGen Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate NextGen Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqGS:NXGN Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 12 Analyst Estimates (S&P Global) See Below
Global Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 29 Stocks 0.7%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1941 Stocks 3.1%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 2%
United States of America Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqGS:NXGN Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2025-03-31
2024-03-31
2023-03-31
2022-03-31 0.00 1.00
2021-03-31 0.00 1.00
2020-04-03
2020-03-31 0.00 1.00
NasdaqGS:NXGN Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2017-10-26 0.000 0.000
2017-08-01 0.000 0.000
2017-05-19 0.000 0.000
2017-01-26 0.000 0.000
2017-01-25 0.000 0.000
2016-10-27 0.000 0.000
2016-07-29 0.000 0.000
2016-07-28 0.000 0.000
2016-05-25 0.000 0.000
2016-05-19 0.000 0.000
2016-01-29 0.700 4.835
2016-01-28 0.700 4.821
2015-10-23 0.700 4.491
2015-10-22 0.700 5.047
2015-07-23 0.700 5.455
2015-05-26 0.700 4.285
2015-05-21 0.700 4.195
2014-10-23 0.700 4.436
2014-07-24 0.700 4.764
2014-05-29 0.700 4.433
2013-10-24 0.700 3.806
2013-07-29 0.700 3.196
2013-05-28 0.700 3.643
2013-05-23 0.700 3.836
2012-10-26 0.700 3.855
2012-07-27 0.700 3.878
2012-05-30 0.700 2.713
2012-01-26 0.700 1.803
2011-10-27 0.700 1.888
2011-07-28 0.700 1.584
2011-05-26 0.700 1.646
2011-01-28 0.700 1.678
2010-10-29 0.600 1.770
2010-07-30 0.600 1.984
2010-05-28 0.600 2.098
2010-02-02 0.600 2.000
2009-11-02 0.600 1.949
2009-10-30 0.600 1.973
2009-08-03 0.600 2.076
2009-07-30 0.600 2.187

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as NextGen Healthcare has not reported any payouts.
  • Unable to verify if NextGen Healthcare's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of NextGen Healthcare's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as NextGen Healthcare has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of NextGen Healthcare's dividends in 3 years as they are not expected to pay a notable one for United States of America.
X
Income/ dividend checks
We assess NextGen Healthcare's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can NextGen Healthcare afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. NextGen Healthcare has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

NXGN Management

 What is the CEO of NextGen Healthcare's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Rusty Frantz
COMPENSATION $6,833,956
AGE 52
TENURE AS CEO 4.8 years
CEO Bio

Mr. John R. Frantz, also known as Rusty, serves as President and Chief Executive Officer of NextGen Healthcare information Systems, LLC. Mr. Frantz has been the President and Chief Executive Officer of NextGen Healthcare, Inc. (formerly, Quality Systems, Inc.) since July 1, 2015. Previously, he served as Senior Vice President and General Manager of Global Dispensing Division, of CareFusion Corp. (“CareFusion”) from 2011 to March 2015, when CareFusion was acquired by Becton, Dickinson and Company. He also served as Vice President of Research and Development, for CareFusion’s Pyxis business unit from 2010 to 2011, as General Manager of CareFusion’s Pyxis Perioperative Solutions from 2008 to 2010 and as CareFusion’s Vice President, Marketing, Supply Technologies from 2007 to 2008. Prior to his employment with CareFusion, Mr. Frantz served as Vice President of Marketing at Cerfidia Solutions, Vice President, Marketing and Product Management at Amphire Solutions, Co-Founder and Vice President of Engineering, at OutPurchase, and held various other management positions in the health care industry. Mr. Frantz holds a Master of Science degree in Engineering from Stanford University and a Bachelor of Science degree in engineering from the Maine Maritime Academy.

CEO Compensation
  • Rusty's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Rusty's remuneration is higher than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the NextGen Healthcare management team in years:

3.9
Average Tenure
56
Average Age
  • The tenure for the NextGen Healthcare management team is about average.
Management Team

Rusty Frantz

TITLE
President
COMPENSATION
$7M
AGE
52
TENURE
4.8 yrs

Jamie Arnold

TITLE
Executive VP
COMPENSATION
$2M
AGE
63
TENURE
4.1 yrs

David Metcalfe

TITLE
Executive VP & Chief Technology Officer
COMPENSATION
$2M
AGE
56
TENURE
4.2 yrs

Jeff Linton

TITLE
Executive VP
COMPENSATION
$1M
AGE
56
TENURE
2.3 yrs

Donna Greene

TITLE
Senior Vice President of Human Resources

John Beck

TITLE
Chief Solutions Officer & Executive VP
TENURE
3.7 yrs

Betty Rabinowitz

TITLE
Chief Medical Officer
TENURE
2 yrs

Asher Dewhurst

TITLE
Investor Relations
Board of Directors Tenure

Average tenure and age of the NextGen Healthcare board of directors in years:

7.3
Average Tenure
56
Average Age
  • The tenure for the NextGen Healthcare board of directors is about average.
Board of Directors

Jeff Margolis

TITLE
Independent Chairman
COMPENSATION
$315K
AGE
55
TENURE
4.4 yrs

Rusty Frantz

TITLE
President
COMPENSATION
$7M
AGE
52
TENURE
4.7 yrs

Craig Barbarosh

TITLE
Independent Vice Chairman
COMPENSATION
$369K
AGE
51
TENURE
4.4 yrs

George Bristol

TITLE
Independent Director
COMPENSATION
$281K
AGE
70
TENURE
11.6 yrs

Morris Panner

TITLE
Independent Director
COMPENSATION
$261K
AGE
56
TENURE
7.3 yrs

Sheldon Razin

TITLE
Chairman Emeritus
COMPENSATION
$315K
AGE
81
TENURE
46.3 yrs

Lance Rosenzweig

TITLE
Independent Director
COMPENSATION
$247K
AGE
56
TENURE
7.9 yrs

Jim Malone

TITLE
Independent Director
COMPENSATION
$277K
AGE
70
TENURE
7.3 yrs

Julie Klapstein

TITLE
Independent Director
COMPENSATION
$265K
AGE
64
TENURE
2.7 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by NextGen Healthcare individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
13. Mar 20 Buy James Arnold Individual 13. Mar 20 13. Mar 20 5,000 $9.20 $46,000
13. Mar 20 Buy Jeffrey Margolis Individual 12. Mar 20 12. Mar 20 10,000 $9.26 $92,600
13. Mar 20 Buy Jeffrey Linton Individual 13. Mar 20 13. Mar 20 575 $8.48 $4,876
12. Sep 19 Sell Ahmed Diaa El Din Ali Hussein Individual 31. Jul 19 23. Aug 19 -865,623 $16.66 $-13,007,939
17. Jun 19 Sell Sheldon Razin Individual 14. Jun 19 14. Jun 19 -21,900 $19.07 $-417,633
13. Jun 19 Sell Sheldon Razin Individual 13. Jun 19 13. Jun 19 -4,018 $19.06 $-76,583
10. Jun 19 Sell Sheldon Razin Individual 07. Jun 19 07. Jun 19 -22,568 $19.10 $-431,049
06. Jun 19 Sell Sheldon Razin Individual 06. Jun 19 06. Jun 19 -1,113 $19.03 $-21,180
05. Jun 19 Sell Sheldon Razin Individual 04. Jun 19 04. Jun 19 -32,301 $19.40 $-619,639
04. Jun 19 Sell George Bristol Individual 03. Jun 19 03. Jun 19 -13,873 $19.29 $-267,007
X
Management checks
We assess NextGen Healthcare's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. NextGen Healthcare has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

NXGN News

Simply Wall St News

Are Investors Undervaluing NextGen Healthcare, Inc. (NASDAQ:NXGN) By 31%?

Using the most recent financial data, we'll take a look at whether the stock is fairly priced by estimating the company's future cash flows and discounting them to their present value. … Generally we assume that a dollar today is more valuable than a dollar in the future, and so the sum of these future cash flows is then discounted to today's value: 10-year free cash flow (FCF) forecast 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 Levered FCF ($, Millions) $52.4m $63.8m $65.5m $77.5m $90.1m $98.6m $105.8m $112.2m $117.8m $122.9m Growth Rate Estimate Source Analyst x3 Analyst x4 Analyst x1 Analyst x1 Analyst x1 Est @ 9.38% Est @ 7.39% Est @ 5.99% Est @ 5.01% Est @ 4.33% Present Value ($, Millions) Discounted @ 9.22% $48.0 $53.5 $50.3 $54.5 $58.0 $58.0 $57.1 $55.4 $53.2 $50.9 ("Est" = FCF growth rate estimated by Simply Wall St) Present Value of 10-year Cash Flow (PVCF)= $538.7m The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. … NasdaqGS:NXGN Intrinsic value, September 2nd 2019 Important assumptions Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows.

Simply Wall St -

Before You Buy NextGen Healthcare, Inc. (NASDAQ:NXGN), Consider Its Volatility

Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market. … This is reasonably close to the market beta of 1, so the stock has in the past displayed similar levels of volatility to the overall market.

Simply Wall St -

Did Changing Sentiment Drive NextGen Healthcare's (NASDAQ:NXGN) Share Price Down By 28%?

View our latest analysis for NextGen Healthcare While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. … We'd be remiss not to mention the difference between NextGen Healthcare's total shareholder return (TSR) and its share price return. … A Different Perspective While the broader market gained around 3.1% in the last year, NextGen Healthcare shareholders lost 28%.

Simply Wall St -

How NextGen Healthcare, Inc. (NASDAQ:NXGN) Could Add Value To Your Portfolio

In the case of NXGN, it is a company with robust financial health as well as an optimistic future outlook. … For those interested in understanding where the figures come from and want to see the analysis, take a look at the report on NextGen Healthcare here. … NasdaqGS:NXGN Past and Future Earnings, August 2nd 2019 Next Steps: For NextGen Healthcare, I've put together three important factors you should look at: Historical Performance: What has NXGN's returns been like over the past?

Simply Wall St -

We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. … NasdaqGS:NXGN Historical Debt, July 10th 2019 A Look At NextGen Healthcare's Liabilities We can see from the most recent balance sheet that NextGen Healthcare had liabilities of US$128.2m falling due within a year, and liabilities of US$28.7m due beyond that. … While NextGen Healthcare has net cash on its balance sheet, it's still worth taking a look at its ability to convert earnings before interest and tax (EBIT) to free cash flow, to help us understand how quickly it is building (or eroding) that cash balance.

Simply Wall St -

With EPS Growth And More, NextGen Healthcare (NASDAQ:NXGN) Is Interesting

So if you're like me, you might be more interested in profitable, growing companies, like NextGen Healthcare (NASDAQ:NXGN). … See our latest analysis for NextGen Healthcare NextGen Healthcare's Earnings Per Share Are Growing. … NextGen Healthcare's earnings per share growth has been so hot recently that thinking about it is making me blush.

Simply Wall St -

Is NextGen Healthcare, Inc.'s (NASDAQ:NXGN) CEO Paid At A Competitive Rate?

Rusty Frantz became the CEO of NextGen Healthcare, Inc. … See our latest analysis for NextGen Healthcare How Does Rusty Frantz's Compensation Compare With Similar Sized Companies? … The graphic below shows how CEO compensation at NextGen Healthcare has changed from year to year.

Simply Wall St -

Why NextGen Healthcare, Inc. (NASDAQ:NXGN) Could Be Worth Watching

(NASDAQ:NXGN), which is in the healthcare services business, and is based in United States, saw a decent share price growth in the teens level on the NASDAQGS over the last few months. … It’s trading around 17% below my intrinsic value, which means if you buy NextGen Healthcare today, you’d be paying a fair price for it. … Since NextGen Healthcare’s share price is quite volatile, we could potentially see it sink lower (or rise higher) in the future, giving us another chance to buy.

Simply Wall St -

Read This Before Judging NextGen Healthcare, Inc.'s (NASDAQ:NXGN) ROE

The formula for return on equity is: Return on Equity = Net Profit ÷ Shareholders' Equity Or for NextGen Healthcare: 6.5% = US$24m ÷ US$376m (Based on the trailing twelve months to March 2019.) Most readers would understand what net profit is, but it’s worth explaining the concept of shareholders’ equity. … Does NextGen Healthcare Have A Good Return On Equity? … One simple way to determine if a company has a good return on equity is to compare it to the average for its industry.

Simply Wall St -

Estimating The Intrinsic Value Of NextGen Healthcare, Inc. (NASDAQ:NXGN)

Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. … A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we need to discount the sum of these future cash flows to arrive at a present value estimate: 10-year free cash flow (FCF) estimate 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 Levered FCF ($, Millions) $33.23 $51.44 $58.20 $73.20 $87.80 $99.80 $109.54 $117.91 $125.19 $131.63 Growth Rate Estimate Source Analyst x3 Analyst x4 Analyst x2 Analyst x1 Analyst x1 Analyst x1 Est @ 9.76% Est @ 7.65% Est @ 6.17% Est @ 5.14% Present Value ($, Millions) Discounted @ 9.69% $30.30 $42.75 $44.10 $50.56 $55.29 $57.29 $57.33 $56.26 $54.46 $52.20 Present Value of 10-year Cash Flow (PVCF)= $500.53m "Est" = FCF growth rate estimated by Simply Wall St The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. … NasdaqGS:NXGN Intrinsic value, May 23rd 2019 Important assumptions We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows.

Simply Wall St -

NXGN Company Info

Description

NextGen Healthcare, Inc. provides ambulatory-focused healthcare software and services solutions in the United States. The company’s principal products include NextGen Enterprise electronic health record (EHR), which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools. Its products also comprise NextGen Enterprise PM, a practice management (PM) solution; and NextGen Office, a cloud-based EHR and PM solution. In addition, the company offers automation and workflow solutions, including NextGen Mobile, NextGen Electronic Healthcare Transactions, NextGen Pre-Service Clearance, and NextGen Patient Payment solutions. Further, it provides analytics, population health, and patient engagement solutions, such as NextGen Population Health Informed Analytics, NextGen Population Health Patient Care Coordination, NextGen Population Health Performance Management, and NextGen Patient Portal solutions. Additionally, the company offers NextGen Connected Health and NextGen Share interoperability solutions; Managed services, including NextGen Managed Cloud, NextGen Financial Suite, and NextGen Contract Audit and Recovery solutions; and professional services. It serves physician managed service organizations, independent physician associations, accountable care organizations, ambulatory care centers, and community health centers through a sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was founded in 1974 and is headquartered in Irvine, California.

Details
Name: NextGen Healthcare, Inc.
NXGN
Exchange: NasdaqGS
Founded: 1974
$611,021,727
65,701,261
Website: http://www.nextgen.com
Address: NextGen Healthcare, Inc.
18111 Von Karman Avenue,
Suite 800,
Irvine,
California, 92612,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGS NXGN Common Stock Nasdaq Global Select US USD 01. Dec 1982
DB QY1 Common Stock Deutsche Boerse AG DE EUR 01. Dec 1982
Number of employees
Current staff
Staff numbers
2,660
NextGen Healthcare employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/03 13:26
End of day share price update: 2020/04/02 00:00
Last estimates confirmation: 2020/03/27
Last earnings filing: 2020/01/24
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.